Tofia e JenaValve Kari Moore e avea ma Ofisa Sili o Tupe

IRVINE, Calif., Me 17, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. ("JenaValve poʻo le "Kamupani"), o se atinaʻe ma le gaosiga o faiga faʻapitoa transcatheter aortic valve replacement (TAVR), i aso nei na faʻasalalau le tofiga o O Kari Moore o le Ofisa Sili o Tupe a le kamupani e amata ia Me 10, 2022. "Matou te fiafia e faʻafeiloaʻi Kari i le au a JenaValve," o le tala lea a le CEO o JenaValve John Kilcoyne. alamanuia tau soifua maloloina. O le malamalama lautele o Kari ma le tomai faʻapisinisi o le a fesoasoani ia i matou e faʻaauau pea le faʻatinoina o la matou fuafuaga faʻafomaʻi ma faʻagasolo a matou Trilogy mo le togafitiga o faʻamaʻi o le aortic valve ® Faʻatauga Faʻatauga mo Faiga o Valve fatu." O Ms. Moore e auai atu i le JenaValve ina ua mae'a ona galue muamua o se Ofisa Sili o Tausitusi mo Envista Holdings Corporation, o se kamupani o oloa gaosi nifo i le lalolagi atoa, lea sa nafa ma galuega tau tausitusi, tupe ma fefa'asoa'iga i le lalolagi atoa. A'o le'i auai atu i le Envista Holdings Corporation, sa avea Ms. Ofisa Tausitusi a le Applied Medical Corporation, ose kamupani fa'afoma'i i le lalolagi atoa o lo'o tu'uina atu tekinolosi ma vaifofo mo taotoga fa'apitoa ma fa'atama'i lautele.Ms. Na amata e Moore ana galuega i PricewaterhouseCoopers, lea sa galue ai o se paaga suetusi, faʻapitoa i le soifua maloloina alamanuia. I le 20 tausaga o lana galuega, Ms. Moore na ave le tele o kamupani faʻalauaʻitele ma fesoasoani ia i latou i le mauaina, faʻateʻaina ma le tuʻuina atu o aitalafu. a BA i Pulega Pisinisi mai le Iunivesite o Kalefonia i Saute ma o se CPA i le setete o Kalefonia. "Ua ou fiafia lava e auai i le JenaValve i se taimi faigata," o le tala lea a Ms. Moore. "Ou te fiafia e galulue faatasi ma le vaega atoa o le JenaValve ao matou faʻaauau pea ona faʻatinoina la matou faʻatupulaia ma le faʻatulagaina o fuafuaga faʻavae aʻo faʻaleleia olaga o tagata gasegase." E uiga i le JenaValve JenaValve Technology, Inc., faʻauluuluga i Irvine, Kalefonia, faʻatasi ai ma nofoaga i Leeds, UK ma Munich, Siamani, atiaʻe ma gaosia le transcatheter aortic valve replacement (TAVR) faiga mo togafitiga o tagata mamaʻi maʻi faʻamaʻi valve aortic.JenaValve e lagolagoina e Bain Capital Life Sciences ma Cormorant Asset Management, faʻapea foʻi ma Europa ma Asia teufaafaigaluega e aofia ai Andera Partners, Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences, VI Partners ma Peijia Medical Limited (HKEx: 9996) . United States: Fa'alogo - Mea Su'esu'e. Fa'atapula'a e le feterale (po'o le US) tulafono mo su'esu'ega fa'aoga.